Vanguard Total Stock Market Index Fund ETF vs DENTSPLY SIRONA Inc — how do they compare? Vanguard Total Stock Market Index Fund ETF trades at $381.94 (market cap $2.30T), while DENTSPLY SIRONA Inc trades at $8.83 (market cap $1.73B). The key difference: Vanguard Total Stock Market Index Fund ETF is far larger — about 1329.5× DENTSPLY SIRONA Inc's market cap, and DENTSPLY SIRONA Inc pays a 5.04% dividend while Vanguard Total Stock Market Index Fund ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold Vanguard Total Stock Market Index Fund ETF for 131 Days and DENTSPLY SIRONA Inc for 72 Days on average.
| VTI | XRAY | |
|---|---|---|
Market Cap | $2.30T | $1.73B |
Volume | 2,982,924 | 6,198,582 |
52-Week High | $384.30 | $14.68 |
52-Week Low | $311.68 | $8.52 |
Typical Hold Time | 131 Days | 72 Days |
Sector | — | Health |
Enterprise Value | — | $3.80B |
Dividend Yield | — | 5.04% |
Signals from Pluang's Aura AI — not financial advice
VTI trades at $379.56, down 0.39% on the day, with a bullish technical signal driven by moving averages. The ETF provides broad U.S. equity exposure, though key valuation and profitability ratios are not publicly disclosed for the fund itself. Recent news highlights its role in diversified portfolios and long-term growth potential.
The outlook for VTI remains positive given its low-cost, diversified structure and historical performance. Risks include market concentration in top holdings and broader economic volatility. Analyst sentiment is generally favorable for long-term investors seeking total market exposure.
DENTSPLY SIRONA (XRAY) trades at $8.69, down 1.76% on the day and near a 52-week low, reflecting ongoing operational challenges. The stock shows a bearish technical trend with weak moving averages, while fundamentals reveal declining revenue, negative net income margins, and elevated debt levels. Recent Q2 2026 earnings beat expectations but sales fell 4.1%, indicating persistent headwinds in dental markets.
The outlook remains cautious due to margin pressure and competitive threats, though analyst consensus suggests upside to a $13.40 price target. Key risks include execution of the turnaround plan, macroeconomic sensitivity, and high leverage. Investment appeal hinges on successful restructuring and recovery in core dental segments.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
The fund employs an indexing investment approach designed to track the performance of the index, which represents approximately 100% of the investable US stock market and includes large-, mid-, small-, and micro-cap stocks. It invests by sampling the index, meaning that it holds a broadly diversified collection of securities that, in the aggregate, approximates the full index in terms of key characteristics.
Read more on VTI →Dentsply Sirona Inc is a global manufacturer and distributor of dental supplies and equipment. The company's operating segments include Technologies & Equipment, which is responsible for the design, manufacture, sales, and distribution of products including dental implants, CAD/CAM systems, orthodontic clear aligner products, imaging systems, treatment centers, instruments, as well as certain healthcare device products, primarily catheters
Read more on XRAY →